One study also assessed the expression of the active form pGSK3β-Y216 and found its overexpression as well, which led to the conclusion that GSK3β is both overexpressed and overactivated in ovarian cancer cells [86]. The gene discussed is GSK3B; the disease is ovarian cancer.